Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-06-02

AUTHORS

Xinyu Ma, Rui Tang, Mei Luo, Zhuotong Zeng, Yaqian Shi, Bingsi Tang, Rong Xiao

ABSTRACT

ObjectiveThis study systematically compares the efficacy and adverse events of mycophenolate mofetil (MMF) and cyclophosphamide (CYC) in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD).MethodsThe EMBASE and PubMed databases were systematically searched to find all relevant studies. Quality assessment, study selection, and data extraction were independently conducted by two reviewers. The mean changes in forced vital capacity (FVC)% and diffusing capacity for carbon monoxide (DLco)% of the patients were selected to be primary outcome measures. Stata software was used for the pooled analysis.ResultsAmong 284 titles screened from multiple databases, six studies met the inclusion criteria (one randomized controlled trial, three prospective observational studies, and two retrospective observational studies). The summary weighted mean difference (WMD) of FVC change in the MMF group compared with the CYC group was − 1.17 (95% CI: − 2.713, 0.373; P = 0.137), and the summary WMD of DLco change in the MMF group compared with the CYC group was 2.245 (95% CI: 0.258, 4.232; P = 0.027). Studies enrolled showed that adverse events were less common in the MMF group.ConclusionsThe efficacy of MMF with respect to FVC and DLco improvement is comparable to that of CYC, and MMF is preferred on the basis of the occurrence of adverse events. Key Points• A systematic review and meta-analysis was conducted to compare the efficacy and adverse events of mycophenolate mofetil and cyclophosphamide in patients with systemic sclerosis-related interstitial lung disease.• The efficacy of MMF with respect to FVC and DLco improvement is comparable to that of CYC, and MMF is preferred on the basis of the occurrence of adverse events. More... »

PAGES

3185-3193

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10067-021-05794-5

DOI

http://dx.doi.org/10.1007/s10067-021-05794-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1138543271

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34080081


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Diseases, Interstitial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mycophenolic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Observational Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Scleroderma, Systemic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China", 
          "id": "http://www.grid.ac/institutes/grid.216417.7", 
          "name": [
            "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ma", 
        "givenName": "Xinyu", 
        "id": "sg:person.011413453757.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011413453757.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China", 
          "id": "http://www.grid.ac/institutes/grid.216417.7", 
          "name": [
            "Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tang", 
        "givenName": "Rui", 
        "id": "sg:person.015154034360.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015154034360.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China", 
          "id": "http://www.grid.ac/institutes/grid.216417.7", 
          "name": [
            "Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luo", 
        "givenName": "Mei", 
        "id": "sg:person.016437106267.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016437106267.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China", 
          "id": "http://www.grid.ac/institutes/grid.216417.7", 
          "name": [
            "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zeng", 
        "givenName": "Zhuotong", 
        "id": "sg:person.01133462143.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133462143.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China", 
          "id": "http://www.grid.ac/institutes/grid.216417.7", 
          "name": [
            "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shi", 
        "givenName": "Yaqian", 
        "id": "sg:person.0605077273.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605077273.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China", 
          "id": "http://www.grid.ac/institutes/grid.216417.7", 
          "name": [
            "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tang", 
        "givenName": "Bingsi", 
        "id": "sg:person.01161535157.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161535157.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China", 
          "id": "http://www.grid.ac/institutes/grid.216417.7", 
          "name": [
            "Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xiao", 
        "givenName": "Rong", 
        "id": "sg:person.01247322455.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247322455.35"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s13075-016-1015-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000742933", 
          "https://doi.org/10.1186/s13075-016-1015-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00296-011-1967-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030201151", 
          "https://doi.org/10.1007/s00296-011-1967-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12931-019-0980-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111515777", 
          "https://doi.org/10.1186/s12931-019-0980-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrdp.2015.2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019573872", 
          "https://doi.org/10.1038/nrdp.2015.2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00408-013-9499-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029983578", 
          "https://doi.org/10.1007/s00408-013-9499-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar2534", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001952823", 
          "https://doi.org/10.1186/ar2534"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-06-02", 
    "datePublishedReg": "2021-06-02", 
    "description": "ObjectiveThis study systematically compares the efficacy and adverse events of mycophenolate mofetil (MMF) and cyclophosphamide (CYC) in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD).MethodsThe EMBASE and PubMed databases were systematically searched to find all relevant studies. Quality assessment, study selection, and data extraction were independently conducted by two reviewers. The mean changes in forced vital capacity (FVC)% and diffusing capacity for carbon monoxide (DLco)% of the patients were selected to be primary outcome measures. Stata software was used for the pooled analysis.ResultsAmong 284 titles screened from multiple databases, six studies met the inclusion criteria (one randomized controlled trial, three prospective observational studies, and two retrospective observational studies). The summary weighted mean difference (WMD) of FVC change in the MMF group compared with the CYC group was\u2009\u2212\u20091.17 (95% CI:\u2009\u2212\u20092.713, 0.373; P\u2009=\u20090.137), and the summary WMD of DLco change in the MMF group compared with the CYC group was 2.245 (95% CI: 0.258, 4.232; P\u2009=\u20090.027). Studies enrolled showed that adverse events were less common in the MMF group.ConclusionsThe efficacy of MMF with respect to FVC and DLco improvement is comparable to that of CYC, and MMF is preferred on the basis of the occurrence of adverse events.\nKey Points\u2022 A systematic review and meta-analysis was conducted to compare the efficacy and adverse events of mycophenolate mofetil and cyclophosphamide in patients with systemic sclerosis-related interstitial lung disease.\u2022 The efficacy of MMF with respect to FVC and DLco improvement is comparable to that of CYC, and MMF is preferred on the basis of the occurrence of adverse events.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10067-021-05794-5", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093299", 
        "issn": [
          "0770-3198", 
          "1434-9949"
        ], 
        "name": "Clinical Rheumatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "40"
      }
    ], 
    "keywords": [
      "systemic sclerosis-related interstitial lung disease", 
      "interstitial lung disease", 
      "mycophenolate mofetil", 
      "adverse events", 
      "MMF group", 
      "lung disease", 
      "CYC group", 
      "systematic review", 
      "efficacy of MMF", 
      "primary outcome measure", 
      "MethodsThe Embase", 
      "summary WMD", 
      "vital capacity", 
      "pooled analysis", 
      "STUDY SELECTION", 
      "ConclusionsThe efficacy", 
      "DLCO changes", 
      "mean change", 
      "outcome measures", 
      "inclusion criteria", 
      "cyclophosphamide", 
      "PubMed database", 
      "mofetil", 
      "STATA software", 
      "mean difference", 
      "patients", 
      "FVC change", 
      "relevant studies", 
      "data extraction", 
      "efficacy", 
      "disease", 
      "FVC", 
      "multiple databases", 
      "group", 
      "EMBASE", 
      "review", 
      "study", 
      "events", 
      "quality assessment", 
      "reviewers", 
      "database", 
      "changes", 
      "occurrence", 
      "improvement", 
      "assessment", 
      "WMD", 
      "differences", 
      "criteria", 
      "summary", 
      "measures", 
      "capacity", 
      "carbon monoxide", 
      "basis", 
      "analysis", 
      "respect", 
      "title", 
      "selection", 
      "monoxide", 
      "extraction", 
      "software"
    ], 
    "name": "Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis", 
    "pagination": "3185-3193", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1138543271"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10067-021-05794-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34080081"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10067-021-05794-5", 
      "https://app.dimensions.ai/details/publication/pub.1138543271"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_877.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10067-021-05794-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10067-021-05794-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10067-021-05794-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10067-021-05794-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10067-021-05794-5'


 

This table displays all metadata directly associated to this object as RDF triples.

228 TRIPLES      22 PREDICATES      101 URIs      87 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10067-021-05794-5 schema:about N043f1d0486ed47aca63c460c1f47c36b
2 N477a6722dc264986a02c741860855d7c
3 N658ac7199b054e66bef1ed2b330010df
4 N818daf13eab14715a19e1bb260183d4a
5 N916f4af990f645b7b58449d7042c989f
6 N981e1f34cc934a7eb98c87bb2cea1d7d
7 Nae2207228f514aada604d3c959033877
8 Nd60d4f28b61a430b836e661a19a6a057
9 Nff0d3f9a62e14c1f9b923d6ada0b313e
10 anzsrc-for:11
11 anzsrc-for:1117
12 schema:author Nf8ae8f020b6244d192a65f57480c0ba3
13 schema:citation sg:pub.10.1007/s00296-011-1967-y
14 sg:pub.10.1007/s00408-013-9499-8
15 sg:pub.10.1038/nrdp.2015.2
16 sg:pub.10.1186/ar2534
17 sg:pub.10.1186/s12931-019-0980-7
18 sg:pub.10.1186/s13075-016-1015-0
19 schema:datePublished 2021-06-02
20 schema:datePublishedReg 2021-06-02
21 schema:description ObjectiveThis study systematically compares the efficacy and adverse events of mycophenolate mofetil (MMF) and cyclophosphamide (CYC) in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD).MethodsThe EMBASE and PubMed databases were systematically searched to find all relevant studies. Quality assessment, study selection, and data extraction were independently conducted by two reviewers. The mean changes in forced vital capacity (FVC)% and diffusing capacity for carbon monoxide (DLco)% of the patients were selected to be primary outcome measures. Stata software was used for the pooled analysis.ResultsAmong 284 titles screened from multiple databases, six studies met the inclusion criteria (one randomized controlled trial, three prospective observational studies, and two retrospective observational studies). The summary weighted mean difference (WMD) of FVC change in the MMF group compared with the CYC group was − 1.17 (95% CI: − 2.713, 0.373; P = 0.137), and the summary WMD of DLco change in the MMF group compared with the CYC group was 2.245 (95% CI: 0.258, 4.232; P = 0.027). Studies enrolled showed that adverse events were less common in the MMF group.ConclusionsThe efficacy of MMF with respect to FVC and DLco improvement is comparable to that of CYC, and MMF is preferred on the basis of the occurrence of adverse events. Key Points• A systematic review and meta-analysis was conducted to compare the efficacy and adverse events of mycophenolate mofetil and cyclophosphamide in patients with systemic sclerosis-related interstitial lung disease.• The efficacy of MMF with respect to FVC and DLco improvement is comparable to that of CYC, and MMF is preferred on the basis of the occurrence of adverse events.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf Nae59f0a121704d7387594ab56d8bef30
26 Ne9b94f02bd9a479697b894ac54e5d78e
27 sg:journal.1093299
28 schema:keywords CYC group
29 ConclusionsThe efficacy
30 DLCO changes
31 EMBASE
32 FVC
33 FVC change
34 MMF group
35 MethodsThe Embase
36 PubMed database
37 STATA software
38 STUDY SELECTION
39 WMD
40 adverse events
41 analysis
42 assessment
43 basis
44 capacity
45 carbon monoxide
46 changes
47 criteria
48 cyclophosphamide
49 data extraction
50 database
51 differences
52 disease
53 efficacy
54 efficacy of MMF
55 events
56 extraction
57 group
58 improvement
59 inclusion criteria
60 interstitial lung disease
61 lung disease
62 mean change
63 mean difference
64 measures
65 mofetil
66 monoxide
67 multiple databases
68 mycophenolate mofetil
69 occurrence
70 outcome measures
71 patients
72 pooled analysis
73 primary outcome measure
74 quality assessment
75 relevant studies
76 respect
77 review
78 reviewers
79 selection
80 software
81 study
82 summary
83 summary WMD
84 systematic review
85 systemic sclerosis-related interstitial lung disease
86 title
87 vital capacity
88 schema:name Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
89 schema:pagination 3185-3193
90 schema:productId N3dd930823499478d9df6bc13ba0c8633
91 N74cc1d1d8068406b95998d0f368e2b30
92 N9b651055529942ab89122a2034490032
93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1138543271
94 https://doi.org/10.1007/s10067-021-05794-5
95 schema:sdDatePublished 2022-05-20T07:38
96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
97 schema:sdPublisher N154d808811654205bde6d513c75af8c3
98 schema:url https://doi.org/10.1007/s10067-021-05794-5
99 sgo:license sg:explorer/license/
100 sgo:sdDataset articles
101 rdf:type schema:ScholarlyArticle
102 N043f1d0486ed47aca63c460c1f47c36b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Lung Diseases, Interstitial
104 rdf:type schema:DefinedTerm
105 N154d808811654205bde6d513c75af8c3 schema:name Springer Nature - SN SciGraph project
106 rdf:type schema:Organization
107 N3dd930823499478d9df6bc13ba0c8633 schema:name doi
108 schema:value 10.1007/s10067-021-05794-5
109 rdf:type schema:PropertyValue
110 N477a6722dc264986a02c741860855d7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Mycophenolic Acid
112 rdf:type schema:DefinedTerm
113 N5b3c086ee81546718e7abf5b6b8d81b5 rdf:first sg:person.0605077273.55
114 rdf:rest Nfdce04d529f04559b9f102b3d6a49fb1
115 N658ac7199b054e66bef1ed2b330010df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Immunosuppressive Agents
117 rdf:type schema:DefinedTerm
118 N74cc1d1d8068406b95998d0f368e2b30 schema:name pubmed_id
119 schema:value 34080081
120 rdf:type schema:PropertyValue
121 N818daf13eab14715a19e1bb260183d4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Retrospective Studies
123 rdf:type schema:DefinedTerm
124 N916f4af990f645b7b58449d7042c989f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Scleroderma, Systemic
126 rdf:type schema:DefinedTerm
127 N9788f9877de94d8f946a93a99c945102 rdf:first sg:person.015154034360.47
128 rdf:rest Nf60b9eb505f3409d93538228602ea84a
129 N981e1f34cc934a7eb98c87bb2cea1d7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Treatment Outcome
131 rdf:type schema:DefinedTerm
132 N9b651055529942ab89122a2034490032 schema:name dimensions_id
133 schema:value pub.1138543271
134 rdf:type schema:PropertyValue
135 Na454630f5c624259a3613dc7fad26d90 rdf:first sg:person.01247322455.35
136 rdf:rest rdf:nil
137 Nae2207228f514aada604d3c959033877 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Cyclophosphamide
139 rdf:type schema:DefinedTerm
140 Nae59f0a121704d7387594ab56d8bef30 schema:issueNumber 8
141 rdf:type schema:PublicationIssue
142 Nd60d4f28b61a430b836e661a19a6a057 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Humans
144 rdf:type schema:DefinedTerm
145 Ne9b94f02bd9a479697b894ac54e5d78e schema:volumeNumber 40
146 rdf:type schema:PublicationVolume
147 Nebf1f32e71374b24b3ccb9a55dbd1cbd rdf:first sg:person.01133462143.09
148 rdf:rest N5b3c086ee81546718e7abf5b6b8d81b5
149 Nf60b9eb505f3409d93538228602ea84a rdf:first sg:person.016437106267.34
150 rdf:rest Nebf1f32e71374b24b3ccb9a55dbd1cbd
151 Nf8ae8f020b6244d192a65f57480c0ba3 rdf:first sg:person.011413453757.04
152 rdf:rest N9788f9877de94d8f946a93a99c945102
153 Nfdce04d529f04559b9f102b3d6a49fb1 rdf:first sg:person.01161535157.47
154 rdf:rest Na454630f5c624259a3613dc7fad26d90
155 Nff0d3f9a62e14c1f9b923d6ada0b313e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Observational Studies as Topic
157 rdf:type schema:DefinedTerm
158 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
159 schema:name Medical and Health Sciences
160 rdf:type schema:DefinedTerm
161 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
162 schema:name Public Health and Health Services
163 rdf:type schema:DefinedTerm
164 sg:journal.1093299 schema:issn 0770-3198
165 1434-9949
166 schema:name Clinical Rheumatology
167 schema:publisher Springer Nature
168 rdf:type schema:Periodical
169 sg:person.01133462143.09 schema:affiliation grid-institutes:grid.216417.7
170 schema:familyName Zeng
171 schema:givenName Zhuotong
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133462143.09
173 rdf:type schema:Person
174 sg:person.011413453757.04 schema:affiliation grid-institutes:grid.216417.7
175 schema:familyName Ma
176 schema:givenName Xinyu
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011413453757.04
178 rdf:type schema:Person
179 sg:person.01161535157.47 schema:affiliation grid-institutes:grid.216417.7
180 schema:familyName Tang
181 schema:givenName Bingsi
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161535157.47
183 rdf:type schema:Person
184 sg:person.01247322455.35 schema:affiliation grid-institutes:grid.216417.7
185 schema:familyName Xiao
186 schema:givenName Rong
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247322455.35
188 rdf:type schema:Person
189 sg:person.015154034360.47 schema:affiliation grid-institutes:grid.216417.7
190 schema:familyName Tang
191 schema:givenName Rui
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015154034360.47
193 rdf:type schema:Person
194 sg:person.016437106267.34 schema:affiliation grid-institutes:grid.216417.7
195 schema:familyName Luo
196 schema:givenName Mei
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016437106267.34
198 rdf:type schema:Person
199 sg:person.0605077273.55 schema:affiliation grid-institutes:grid.216417.7
200 schema:familyName Shi
201 schema:givenName Yaqian
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605077273.55
203 rdf:type schema:Person
204 sg:pub.10.1007/s00296-011-1967-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1030201151
205 https://doi.org/10.1007/s00296-011-1967-y
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/s00408-013-9499-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029983578
208 https://doi.org/10.1007/s00408-013-9499-8
209 rdf:type schema:CreativeWork
210 sg:pub.10.1038/nrdp.2015.2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019573872
211 https://doi.org/10.1038/nrdp.2015.2
212 rdf:type schema:CreativeWork
213 sg:pub.10.1186/ar2534 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001952823
214 https://doi.org/10.1186/ar2534
215 rdf:type schema:CreativeWork
216 sg:pub.10.1186/s12931-019-0980-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111515777
217 https://doi.org/10.1186/s12931-019-0980-7
218 rdf:type schema:CreativeWork
219 sg:pub.10.1186/s13075-016-1015-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000742933
220 https://doi.org/10.1186/s13075-016-1015-0
221 rdf:type schema:CreativeWork
222 grid-institutes:grid.216417.7 schema:alternateName Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China
223 Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
224 Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
225 schema:name Department of Dermatology, The Second Xiangya Hospital, Central South University, #139 Road Renmin, 410011, Changsha, Hunan, China
226 Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
227 Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
228 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...